enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
12.00
+0.08 (0.67%)
Apr 28, 2026, 11:13 AM EDT - Market open
enVVeno Medical Employees
enVVeno Medical had 33 employees as of December 31, 2025. The number of employees decreased by 4 or -10.81% compared to the previous year.
Employees
33
Change (1Y)
-4
Growth (1Y)
-10.81%
Revenue / Employee
n/a
Profits / Employee
-$590,061
Market Cap
7.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | -4 | -10.81% |
| Dec 31, 2024 | 37 | 6 | 19.35% |
| Dec 31, 2023 | 31 | 1 | 3.33% |
| Dec 31, 2022 | 30 | 6 | 25.00% |
| Dec 31, 2021 | 24 | 5 | 26.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Vivos Therapeutics | 262 |
| Co-Diagnostics | 115 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| Sintx Technologies | 32 |
| Tenon Medical | 26 |
NVNO News
- 4 weeks ago - enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - Accesswire
- 7 weeks ago - NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - GlobeNewsWire
- 2 months ago - enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Accesswire
- 3 months ago - enVVeno Medical Announces Reverse Stock Split - Accesswire
- 5 months ago - enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Accesswire
- 5 months ago - enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Accesswire
- 6 months ago - enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 7 months ago - enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment - Accesswire